DP, R., & A, R. (2017). Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy. Dove Medical Press.
Chicago Style (17th ed.) CitationDP, Roggeri, and Roggeri A. Economic Impact of the Use of Rifaximin 550 Mg Twice Daily for the Treatment of Overt Hepatic Encephalopathy in Italy. Dove Medical Press, 2017.
MLA (8th ed.) CitationDP, Roggeri, and Roggeri A. Economic Impact of the Use of Rifaximin 550 Mg Twice Daily for the Treatment of Overt Hepatic Encephalopathy in Italy. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.